Volume 8, Number 8—August 2002
Research
DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice
Table
Effect of DNA vaccination on replication of HK/486 challenge virus in mouse lungsa
Immunization | No. mice | Lung titer +/- SE |
---|---|---|
Expt 1A | ||
A/NP+A/M DNA | 6 | 5.7 ± 0.33 |
B/NP + blank DNA | 6 | 6.9 ± 0.18b |
None | 6 | 6.9 ± 0.22c |
Expt 1B | ||
Live X-31 virus | 4 | 3.6 ± 0.36d |
None | 4 | 7.1 ± 0.1 |
aMice were immunized intramuscularly with 100 μg each of influenza A nucleoprotein and matrix DNA (A/NP+A/M DNA) or controls with 100 μg each of influenza B nucleoprotein DNA (B/NP)+blank DNA (total dose 200 μg/mouse on each occasion), three times at 2-week intervals. Two weeks after the last dose of DNA, mice were challenged with 100 mouse infectious dose (MID)50 of HK/486 intranasally. X31 virus-primed mice and their controls were challenged along with DNA-vaccinated mice. On day 6 after challenge, mice were sacrificed and lungs collected for titration of virus infectivity.
bDiffers significantly from A/NP+A/M group by analysis of variation (ANOVA), p=0.0082.
cDiffers significantly from A/NP+A/M group by ANOVA, p=0.011.
dDiffers significantly from unimmunized group by ANOVA, p<0.001.